SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Since the end of 2015, the stock has appreciated by 0% representing an annual average growth of %.
At the end of 2020, the firm traded at price to earnings of -7.89x. Over the last five years, this multiple achieved a high of -7.89x in 2020 and a low of -7.89x in 2020 with an average of -7.89x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at -11.2x at the end of 2020.
At the end of 2020, the company had a net debt of CZK 47.0 mil, or -2.09x of EBITDA and 62.6% of equity. The firm generated an average return on equity of -41.7% for its shareholders in the last five years and an average dividend yield of 0%.
You can see all the company’s data at SimpleCell Europe profile, or you can download a report on the company in the report section.